Cabazitaxel with abiraterone versus abiraterone alone randomized trial for extensive disease following docetaxel: The CHAARTED2 trial of the ECOG-ACRIN Cancer Research Group (EA8153).

Autor: Kyriakopoulos, Christos, Chen, Yu-Hui, Jeraj, Robert, Duan, Fenghai, Luo, Jun, Antonarakis, Emmanuel S., Tripathi, Abhishek, Kosoff, David, Garje, Rohan, Pachynski, Russell Kent, Parikh, Rahul Atul, Harzstark, Andrea, Adra, Nabil, Maughan, Benjamin L., Zakharia, Yousef, Corn, Paul Gettys, Liu, Glenn, Carducci, Michael Anthony
Zdroj: Journal of Clinical Oncology; 2024 Supplement 17, Vol. 42, pLBA5000-LBA5000, 83p
Databáze: Supplemental Index